Relafen 750, containing naproxen sodium, presents a intriguing case from a biochemical perspective. Its mechanism of action involves blocking cyclooxygenase (COX) enzymes, specifically COX-2, which results in a reduction of prostaglandin synthesis . This biochemical pathway directly influences inflammation and pain perception, highlighting its role